The Oncidium foundation is a corporate member of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Value Initiative program to advance the crucial role of Nuclear Medicine and Molecular Imaging to the medical community, regulators, patients and the general public. Check out our article in their January 2021 newsletter.
Learn more about the SNMMI Value Initiative >>
Other news & events
- News12.05.2026
#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists
Read more - News11.05.2026
Oncidium foundation partners with Curium to expand access to Radioligand Therapy worldwide
Read more - News22.04.2026
Addressing Barriers to Radioligand Therapy at the European Parliament
Read more
